Digital Health Monthly: Scientific Webinar Series
Advancing Digital Measures from Scientific Rigor to Real‑World Impact
Insights and Key Lessons Learned at ADDS 2026
Upcoming Digital Health Monthly:
Scientific Webinar Series
Accelerating DHT Research and Drug Development with Open-Source Big Data from Population Studies
Tuesday, December 3 @ 12 PM ET
Digital Health Monthly: Scientific Webinar Series
Sensor-based DHTs are shedding an illuminating light on how people function in their real-world environments. Drug developers, researchers, patients, and regulators are realizing the multifaceted value sensor-based DHTs can bring to clinical research.
As their adoption continues to grow, the ActiGraph team is excited to continue ‘Digital Health Monthly’, a monthly series of science-focused webinars to share the latest high-impact developments in clinical research from innovators in the digital health field. Each month, we feature brief data-driven presentations from clinical researchers, data scientists, and biostatisticians on a focused topic with dedicated time for audience Q&A. We believe that together, we can move the digital health technology field forward faster, and we are excited for this opportunity to facilitate important discussions on the latest research with members of the digital health community.
The annual Ametris Digital Data Summit (ADDS) 2026 convened regulators, biopharma leaders, scientific researchers, and technology innovators for three days of scientific presentations and collaborative discussions exploring how digital health technologies (DHTs) are advancing outcomes measurement in clinical research.
This Digital Health Monthly webinar highlights the most impactful scientific discussions, regulatory perspectives, and real-world use cases shared during ADDS 2026. This session synthesizes insights from the Pre-Conference Huntington’s Disease (HD) Workshop and the main conference agenda (Days 1 and 2), where attendees examined how digital measurement is evolving—from early exploration toward validated endpoints capable of informing regulatory decisions.
Discussion topics include:
- Aligning digital endpoints with regulatory expectations
- The evolving role of AI in digital measurement—what’s possible now and what’s coming next
- Accelerating digital endpoint adoption through pre-competitive collaboration
We also highlight real-world use cases spanning mobility, physical activity, sleep, scratch detection, and adverse event monitoring.
